Subscribe to our Newsletters !!

    Pandemic

    New COVID-19 testing innovation is a less expensive, quicker choice to tube-based RT-PCR tests

    Throughout the COVID-19 pandemic, supply chain shortages of reagents and test kits have restricted the rapid expansion of clinical testing required to contain the virus. Its accuracy was 100 percent predictive in clinical trials, researchers explain in The Journal of Molecular Diagnostics, published by Elsevier. Sensitivity is critical for early detection of COVID-19 infection where

    Scientists test a library of lipid-based compounds to empower safe RNA drug delivery to Lungs

    Japan’s Hokkaido University researchers created and tested a collection of lipid-based compounds in order to deliver RNA drugs safely and effectively to the lungs. The findings were published in Materials Horizons. The COVID-19 pandemic response made it all more familiar with RNA vaccines. These vaccines carry genetic code into the cells, which triggers the production

    Novel antibody candidate shows powerful binding to different SARS-CoV-2 variant mutations

    Twist Bioscience Corporation today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19. The Coronavirus Immunotherapy Consortium (CoVIC) is an academic-industry-non-profit

    India has reported its first case of monkeypox

    The monkeypox virus is a member of the same virus family as smallpox. Monkeypox symptoms can be similar to smallpox, but are milder and rarely fatal. Monkeypox does not have a connection to chickenpox. India reported its first monkeypox case on Thursday. A Keralite returning from the UAE tested positive for the virus. The Centre